Excited to say that I have been named in Stanford University's World Top 2% of scientists for the second year in a row for my chemistry research. #university#research#chemistry
https://t.co/ctJH3Rox76
We've got drugs to help those hospitalised with COVID-19 (dexamethasone and remdesivir), but this could be the first drug (interferon-beta) that we can use to stop people from getting seriously sick with the virus.
https://t.co/ixpCNLam17 via @ConversationEDU
hort article by my colleague (Andrew Barlett) and I about the NDMA contamination of ranitidine heartburn medicines. #ranitidine#CANCER
https://t.co/6okgBK5zya
PLOS ONE is excited to announce a #CallForPapers on Targeted Anticancer Therapies & Precision Medicine in Cancer! The Collection will explore driver genes, drug discovery & resistance, early detection & screening, and more. #Cancer https://t.co/RdSdatj5pb
@allyhan6 Hmmmmm. I’m not a fan of this article. Written by an osteopath with a self declared long list of conflicts-of-interest who links to badly designed studies that show osteopathy not worse than other treatments.
Old school platinum-based drugs are here to stay. From our recent study, nearly half of all chemotherapy patients received a platinum drug (cisplatin, carboplatin, oxaliplatin) as part of their treatment. https://t.co/ZF32hyj6Pf